MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup

MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup

The joint venture with generative AI firm Hologen hands MeiraGTx $200 million up front as well as other financial perks — a “transformative” deal, according to the company’s CEO.

MeiraGTx and Hologen launch AI-backed gene therapy venture - Pharmaceutical Technology

The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from Hologen.

MeiraGTx teams with cryptic AI startup, co-founded by Eric Schmidt, to advance Parkinson's gene therapy

A small-cap biotech developing gene therapies is spinning out its Parkinson’s disease program into a new company in partnership with a secretive AI startup co-founded by former Google CEO Eric Schmidt. MeiraGTx